$NASDAQ:NTLA

INTELLIA THERAPEUTICS Shares Plummet 1.11% as Bears Reassert Dominance
Gallery

INTELLIA THERAPEUTICS Shares Plummet 1.11% as Bears Reassert Dominance

Trending News ☀️ Intellia Therapeutics Intrinsic Value – INTELLIA THERAPEUTICS ($NASDAQ:NTLA) is a biotechnology company that specializes in the development [...]

By GoodWhale|January 7, 2023|Categories: Intrinsic Value|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

UBS Asset Management Americas Boosts Stake in Intellia Therapeutics,

Trending News ☀️ The company is dedicated to developing potential treatments for serious diseases that are currently untreatable with existing [...]

By GoodWhale|December 16, 2022|Categories: Biotechnology|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

Intellia Therapeutics Prices Public Offering of Common Stock
Gallery

Intellia Therapeutics Prices Public Offering of Common Stock

Trending News 🌥️ Intellia Therapeutics Intrinsic Stock Value – Intellia Therapeutics ($NASDAQ:NTLA) is a biotech company that uses CRISPR-based gene [...]

By GoodWhale|December 2, 2022|Categories: Intrinsic Value|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

Is Intellia Therapeutics a Good Stock to Buy at its Current Price?

Trending News ☀️ Intellia Therapeutics ($NASDAQ:NTLA) is a biotech company that uses CRISPR technology to develop treatments for various diseases. [...]

By GoodWhale|November 25, 2022|Categories: Biotechnology, Market Price|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

Chardan Capital Weighs In On Intellia Therapeutics’ FY2022 Earnings
Gallery

Chardan Capital Weighs In On Intellia Therapeutics’ FY2022 Earnings

Trending News 🌥️ Intellia Therapeutics ($NASDAQ:NTLA) is a leading biopharmaceutical company that uses cutting-edge gene editing technology to develop therapies [...]

By GoodWhale|November 19, 2022|Categories: Earnings Report|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

Intellia Therapeutics: The Future of Gene Editing

Trending News 🌥️ Intellia Therapeutics ($NASDAQ:NTLA) is a leading gene editing company that is developing CRISPR-based therapies to treat a [...]

By GoodWhale|November 12, 2022|Categories: Biotechnology|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

Intellia Therapeutics Soars After EF Hutton Upgrade

Trending News 🌥️ Intellia Therapeutics ($NASDAQ:NTLA) is a company that uses cutting-edge technology to develop treatments for serious diseases. The [...]

By GoodWhale|November 3, 2022|Categories: Biotechnology|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

INTELLIA THERAPEUTICS: A Smart Investment in Uncertain Times
Gallery

INTELLIA THERAPEUTICS: A Smart Investment in Uncertain Times

Trending News ☀️ Intellia Therapeutics Stock Fair Value – INTELLIA THERAPEUTICS ($NASDAQ:NTLA) is a clinical-stage biopharmaceutical company developing CRISPR-based gene [...]

By GoodWhale|October 7, 2022|Categories: Intrinsic Value|Tags: $NASDAQ:NTLA, Biotechnology, NASDAQ|0 Comments

Intellia Therapeutics’ CRISPR candidate NTLA-2002 shows promise in early clinical trial
Gallery

Intellia Therapeutics’ CRISPR candidate NTLA-2002 shows promise in early clinical trial

Trending News ☀️ Intellia Therapeutics Intrinsic Value – Intellia Therapeutics($NASDAQ:NTLA), Inc announced interim data for its CRISPR therapeutic candidate NTLA-2002 [...]